U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,528 records

Showing results for "drugs".

  1. #06 Developmental Delays ADHD, and Autism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

  2. #06 Developmental Delays ADHD, and Autism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

  3. #06 Developmental Delays ADHD, and Autism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Autism treatments and drugs. [internet].

  4. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - A few years ago, these drugs were all off label for autism, depression, augmentation of depression, … Actually, we refrained from doing pooled analyses across, drugs in response to reviewers comments … So, we think the report is suitably restrained on drawing conclusions across drugs. … As these drugs are approved for use in MDD, rationale for inclusion of the data in the report should … The drugs are still included in the chart for comparative purposes.

  5. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
    May 15, 2017 - Newly approved drugs and those under review by the FDA are described in Section B (see Table 1) above … Few data are available on efficacy for these drugs; even less is known about how their effectiveness … and harms compared with that of existing drugs. … What has Changed New drugs: Additional clinical trials of three biosimilar drugs and a tsDMARD (an … Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

  6. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - , just as non- biologics for psoriasis are not considered a “class” of drugs either. … We have added the terms biologic and nonbiologic to our glossary with a listing of the drugs which … Suggest specifically mentioning the nonbiologic drugs. Thank you for this suggestion. … Are they naïve to both drugs (mtx, adalimumab, etanercept?) Thank you for this suggestion. … More information about each of the drugs and phototherapy would be helpful.

  7. Introduction (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
    February 01, 2009 - Annual age-specific utilization of DMARDs, glucocorticoids, non-steroidal anti- inflammatory drugs (NSAIDs … rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology Effective Health Care … 8 Introduction The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … Interestingly, about 10% of patients were not using any study drugs on the index dates. … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis

  8. Treatments for Adults with Schizophrenia: A Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Second-Generation Antipsychotic Drugs Aripiprazole (Abilify®, Aristada™*) Asenapine (Saphris® ), … and in 2013 for 2nd versus 2nd generation drugs. … Consensus development conference on antipsychotic drugs and obesity and diabetes. … Drug Class Review of Atypical Antipsychotic Drugs; Update 3. … Drug Class Review: Second Generation Antipsychotic Drugs. Final Report - Update 4.

  9. depression-pregnancy-postpartum-protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
    March 29, 2013 - Coadministration of other psychoactive drugs, specifically, antipsychotics, antianxiety agents (e.g … ., benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs. … Drugs not listed below will not be included (e.g., monoamine oxidase inhibitors). Table 1. … • The drugs listed above in Table 1 when compared with each other.

  10. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the two topics for which (1) preliminary phase III data for drugs were … Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. … CNS Drugs. 2014 Dec;28(12):1185-9. … CNS Drugs. 2013 Jul;27(7):505-14. Also available: http://dx.doi.org/10.1007/s40263- 013-0076-8.

  11. Arthritis and Nontraumatic Joint Disease (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - Tarrytown (NY): Regeneron Pharmaceuticals, Inc.; [accessed 2011 Aug 10]. [1 p]. … Tarrytown (NY): Regeneron Pharmaceuticals; 2009 Jun 11 [accessed 2011 May 23]. [2 p]. … Drugs Today 2009;45(6):423-430. … In: 29th Annual Healthcare Conference; Regeneron Pharmaceuticals, Inc; 2011 Jan 10. … Drugs R D 2008;9(3):197-202. PMID: 18457473 82. Ratner M.

  12. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 6. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 01 [accessed 2013 Jun 05]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 21. 45 p. 14.

  13. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the three topics for which (1) preliminary phase III data for drugs or … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81. … Anti- obesity drugs: Past, present and future. Dis Model Mech. 2012 Sep;5(5):621-6.

  14. Medicare Prescription Drug Coverage | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/medicare-prescription-drug-coverage

  15. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - Patients With the Same Treatment Indication: “Alternative Drug Users” Selecting comparison drugs that … have the same per- ceived medical indication for head-to-head comparisons of active drugs will reduce … In studies of the effectiveness of drugs, it is question- able whether to include patients who have a … In routine care, adherence to drugs is unfortunately substantially lower than in RCTs. … Selective prescribing can lead to over-estimation of the benefits of lipid-lowering drugs.

  16. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

  17. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

  18. Hip-Fracture-Pain Consumer (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
    May 01, 2011 - Some common names for these drugs are morphine, codeine, and oxycodone. … Nonsteroidal anti-inflammatory drugs or NSAIDs. … Some common names for these drugs are ibuprofen and naproxen.

  19. PULMONARY with "Discussions" in Exec Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

  20. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Study did not compare specific drugs. … Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid … Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis … Evidence Table Author, Year Study Design Study name Drugs Year conducted N, Population F/U … Author, Year Study Design Study name Drugs Year conducted N, Population F/U Length Efficacy
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites